Can we predict frailty in serious illness? a large study investigates
NCT ID NCT07740239
First seen Jul 31, 2026 · Last updated Jul 31, 2026
Summary
This study looks at why some older adults with serious conditions like cancer or fractures become vulnerable or frail. Researchers will follow about 1500 patients to find out how common different causes of vulnerability are and how they affect outcomes like survival and quality of life. The goal is to see if current screening tools work well for these patients and to improve how we detect and address vulnerability.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- This could lead to better ways to identify and address vulnerability in older patients with serious illnesses, potentially improving their quality of life and survival.
- What could go wrong
- As an observational study, it cannot prove cause and effect. The findings may not apply to all patients or settings, and the study's large scope may introduce complexities.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tampere University Hospital
RECRUITINGTampere, Finland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Could deep breaths before surgery ward off Post-Op confusion?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- A second look: MRI screening may spot hidden prostate cancers
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer